Translating data on antihypertensive drugs into clinical practice

American Journal of Hypertension

Volumn 11, Issue 6 II SUPPL., 1998, Pages

  Weber, Michael A ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Antihypertensive drugs; Hypertension; Treatment

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; HEART FAILURE; HYPERTENSION; KIDNEY FAILURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031848223     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(98)00061-2     Document Type: Review

References (25)

1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-183.
2. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
3. Weber MA, Laragh JH: Hypertension: steps forward and steps backward: The Joint National Committee Fifth Report. Arch Intern Med 1993;153:149-152.
4. Tobian L, Brunner HR, Cohn JN, et al: Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V consensus guidelines. Am J Hypertens 1994;7:859-872.
5. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993;153:598-615.
6. Materson BJ, Reda DJ, Cushman WC, et al: Single drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.
7. Weber MA: Coronary heart disease and hypertension. Am J Hypertens 1994;7:146S-153S.
8. Weber MA, Smith DHG, Neutel JM, et al: Arterial properties of early hypertension. J Hum Hypertens 1991;5:417-422.
9. Reaven GM: Role of insulin resistance in human disease (1988 Banting Lecture). Diabetes 1989;37: 1595-1607.
10. Brunner HR, Laragh JH, Baer L, et al: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972;286:441-449.
11. Messerli FH, Weber MA, Brunner HR: Angiotensin II receptor inhibition. Arch Intern Med 1996;156:1957-1965.
12. Chobanian AV, Haudenschild CC, Nickerson C, Drago R: Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990;15: 327-331.
13. Cohn JN: The prevention of heart failure: a new agenda. N Engl J Med 1992;327:725-727.
14. Pfeffer MA, Braunwald E, Moye LA, et al: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-677.
15. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, et al: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
16. Alderman MH, Cohen H, Roque R, Madhavan S: Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertension patients. Lancet 1997;349:594-598.
17. Weber MA: Angiotensin II receptor antagonists of the treatment of hypertension. Cardiology in Review 1997; 5(2):72-81.
18. Pitt B, Segal R, Martinez FA, et al: Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-752.
19. Psaty BM, Heckbert SR, Koepsell TD, et al: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
20. Packer M, O'Conner CM, Ghali JK, et al: PRAISE Study: effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335: 1107-1114.
21. Gong L, Zhang W, Zhu Y, et al: Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996;14: 1237-1245.
22. Staessen JA, Fagard R, Thijs L, et al: Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-763.
23. Psaty BM, Smith NL, Siscovick DS, et al: Low dose diuretics, but not high-dose diuretics and β-blockers, reduce coronary heart disease and total mortality (Review). JAMA 1997;277:739-745.
24. Prisant LM, Weir MR, Papademetriou V, et al. Low dose drug combination therapy: an alternative first line approach to hypertension. Am Heart J 1995;130:359-366.
25. Weber MA, Zola BE, Neutel JM: Combination drug therapy: focus on hypertension, in Frishman WH, Sonnenblick EH (eds): Cardiovascular Pharmacotherapeutics. McGraw-Hill, New York, 1997, pp 481-497.